Amyloidogenic proteins in the SARS-CoV and SARS-CoV-2 proteomes
Bhardwaj T. et al, (2023), Nature Communications
Potential of ADAM 17 Signal Peptide To Form Amyloid Aggregates in Vitro
Bhardwaj T. and Giri R., (2023), ACS Chemical Neuroscience
Investigating the conformational dynamics of Zika virus NS4B protein.
Bhardwaj T. et al, (2022), Virology, 575, 20 - 35
Reprofiling of approved drugs against SARS-CoV-2 main protease: an in-silico study.
Kumar P. et al, (2022), J Biomol Struct Dyn, 40, 3170 - 3184
Role of structural disorder in the multi-functionality of flavivirus proteins.
Kapuganti SK. et al, (2022), Expert Rev Proteomics, 19, 183 - 196
Mitoxantrone dihydrochloride, an FDA approved drug, binds with SARS-CoV-2 NSP1 C-terminal.
Kumar P. et al, (2022), RSC Adv, 12, 5648 - 5655
Microsecond simulations and CD spectroscopy reveals the intrinsically disordered nature of SARS-CoV-2 spike-C-terminal cytoplasmic tail (residues 1242-1273) in isolation.
Kumar P. et al, (2022), Virology, 566, 42 - 55
One microsecond MD simulations of the SARS-CoV-2 main protease and hydroxychloroquine complex reveal the intricate nature of binding.
Kumar P. et al, (2022), J Biomol Struct Dyn, 40, 10763 - 10770
The signal peptide of the amyloid precursor protein forms amyloid-like aggregates and enhances Aβ42 aggregation
Gadhave K. et al, (2021), Cell Reports Physical Science, 2
Conformational dynamics of 13 amino acids long NSP11 of SARS-CoV-2 under membrane mimetics and different solvent conditions.
Gadhave K. et al, (2021), Microb Pathog, 158
Salvianolic acid B noncovalently interacts with disordered c-Myc: a computational and spectroscopic-based study.
Singh A. et al, (2021), Future Med Chem, 13, 1341 - 1352
A novel inhibitor L755507 efficiently blocks c-Myc-MAX heterodimerization and induces apoptosis in cancer cells.
Singh A. et al, (2021), J Biol Chem, 297
Understanding COVID-19 via comparative analysis of dark proteomes of SARS-CoV-2, human SARS and bat SARS-like coronaviruses.
Giri R. et al, (2021), Cell Mol Life Sci, 78, 1655 - 1688
Zika virus NS4A N-Terminal region (1-48) acts as a cofactor for inducing NTPase activity of NS3 helicase but not NS3 protease.
Kumar D. et al, (2020), Arch Biochem Biophys, 695
Exploring the SARS-CoV-2 structural proteins for multi-epitope vaccine development: an in-silico approach.
Kumar A. et al, (2020), Expert Rev Vaccines, 19, 887 - 898
Japanese encephalitis virus - exploring the dark proteome and disorder-function paradigm.
Bhardwaj T. et al, (2020), FEBS J, 287, 3751 - 3776